Evidence map›Paper›PMID 26647971›Full record

Trial reportNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

Cannabinoid Modulation of Frontolimbic Activation and Connectivity During Volitional Regulation of Negative Affect.

Stephanie M Gorka, K Luan Phan, Maryssa Lyons, Shoko Mori, Mike Angstadt, Christine A Rabinak

Registry-linked trialOpen access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07123467 (Cannabidiol-Enhanced Cognitive Behavioral Therapy for Generalized Anxiety Disorder), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07123467 phase3recruitingnot on this mapstarted 2025, after this paper: background citation

Cannabidiol-Enhanced Cognitive Behavioral Therapy for Generalized Anxiety Disorder

TypeinterventionalSponsorWayne State UniversityRan2025 to 2027Enrolled90ConditionsGeneralized Anxiety Disorder (GAD), Anxiety DisordersArmsLow-Dose Cannabidiol, Placebo Matched to Moderate-Dose Cannabidiol, Moderate-Dose Cannabidiol, Placebo Matched to Low-Dose Cannabidiol
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Stephanie M GorkaDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
K Luan PhanDepartment of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
Maryssa LyonsDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Shoko MoriDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Mike AngstadtDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
Christine A RabinakDepartment of Psychiatry, University of Michigan, Ann Arbor, MI, USA.
University of Michigan–Ann Arbor · USJesse Brown VA Medical Center · USUniversity of Illinois Chicago · USWayne State University · US

Funding

MICHIGAN INSTITUTE FOR CLINICAL AND HEALTH RESEARCH (MICHR) (UL1): (BPCA)UL1RR024986 · NCRR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHANLEY, THOMAS P. · 2007 to 2011
$51.2M
Michigan Institute for Clinical and Health Research (MCHR)UL1TR000433 · NCATS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MASHOUR, GEORGE ALEXANDER · 2012 to 2016
$49.9M
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCHUL1RR029879 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI MAZZONE, THEODORE · 2009 to 2011
$11.0M
Cannabinoid Control of Fear Extinction Neural Circuits In HumansR21MH093917 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI PHAN, K. LUAN · 2012 to 2013
$431k
NCATS NIH HHS UL1 TR000433NCRR NIH HHS UL1 RR024986NCRR NIH HHS UL1 RR029879NIMH NIH HHS R21 MH093917
6 · The paper itself

Abstract

Behavioral and brain research indicates that administration of Δ(9)-tetrahydrocannabinol (THC) alters threat perception and enhances the suppression of conditioned fear responses via modulation of the frontolimbic circuit. No prior studies, however, have examined whether THC also affects volitional forms of emotion processing such as cognitive reappraisal. The aim of the current study was therefore to examine the effects of THC on frontolimbic activation and functional connectivity during cognitive reappraisal in a sample of healthy adults. The study was a randomized, double-blind, placebo-controlled, between-subject design and all participants ingested either an oral dose of synthetic THC (n=41) or placebo (n=37) before completion of an emotion regulation task during functional magnetic resonance imaging (fMRI). Functional connectivity was assessed using generalized psychophysiological interaction (gPPI) analyses. Results indicated that although there were no group differences in self-reported attenuation of negative affect during cognitive reappraisal, relative to placebo, THC increased amygdala activation and reduced amygdala and dorsolateral prefrontal cortex (dlPFC) functional coupling during cognitive reappraisal of emotionally negative pictures. This suggests that in addition to automatic emotional processes, THC affects frontolimbic functioning during cognitive reappraisal.

Indexed as

AdultAffectAmygdalaArousalBrain MappingCannabinoid Receptor AgonistsCognitionDouble-Blind MethodDronabinolFemaleHealthy VolunteersHumansImage Processing, Computer-AssistedMaleNeural PathwaysNeuropsychological TestsCannabinoid Receptor AgonistsDronabinolOxygen

Identifiers

PMID26647971
PMCPMC4869058
OpenAlexW2295649932

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.